Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_assertion type Assertion NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_head.
- NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_assertion wasGeneratedBy ECO_0000203 NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_provenance.
- NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_assertion wasDerivedFrom befree-2016 NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_provenance.
- NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_assertion SIO_000772 23274758 NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_provenance.
- NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_assertion evidence source_evidence_literature NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_provenance.
- NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_assertion description "[In conclusion, vandetanib might be effective in NSCLC with EGFR mutations that lack PTEN expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_provenance.